冠状动脉气球血管整形,支架和支架
Robert A Byrne1, Gregg W Stone2, John Ormiston3
1Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; Deutsches Zentrum für Herz-Kreislaufforschung (German Centre for Cardiovascular Research), Munich, Germany.
Lancet (London, England)
|August 24, 2017
概括
自1977年以来,穿皮冠状动脉干预已经显著发展,从气球血管造形到药物释放支架. 目前正在进行的创新旨在进一步改善冠状动脉疾病的治疗结果.
科学领域:
- 心脏病学
- 干预心脏病学
- 医疗设备技术
背景情况:
- 穿皮冠状动脉干预 (PCI) 已成为心血管医学的基石.
- 这一程序自创立以来已经经历了40年的快速技术发展.
- 早期的PCI方法面临的局限性包括缩和手术并发症.
研究的目的:
- 审查穿皮冠状动脉干预技术的历史进展.
- 突出技术代对程序结果和患者护理的影响.
- 讨论冠状动脉干预装置的现状和未来潜力.
主要方法:
- 穿皮冠状动脉干预技术的历史审查.
- 分析从气球血管整形到药物释放支架的演变.
- 讨论冠状动脉干预装置的局限性和改进.
主要成果:
- 气球血管整形受到解剖,反弹和高静止率的限制.
- 支架改善了早期的结果,
- 药物释放的支架显著减少了复杂的PCI.
- 生物吸收性支架是有前途的, 但尚未与常规支架相匹配.
结论:
- 技术进步,特别是药物释放支架, 极大地改善了穿皮冠状动脉干预的结果.
- 虽然可生物吸收的支架提供了未来的潜力,但目前的金属药物释放支架仍然是复杂疾病的标准.
- 在PCI的持续进展也归因于冠心内成像和药物治疗的进步.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
324
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
324
Peripheral Artery Disease III: Interprofessional Care
403
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
403
Angina IV: Management
347
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
347
Acute Coronary Syndrome IV: Interprofessional Care
332
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
332


